Up next

Autoplay

Nivolumab + chemotherapy in previously untreated stage III or IV Hodgkin lymphoma

0 Views • 07/09/23
Share
Embed
administrator
administrator
Subscribers
0

[Oncoinfo – Istantanee di Oncologia: seguici su http://oncoinfo.it] The SWOG S1826 trial could change the treatment of classic Hodgkin lymphoma forever. Why and how? We asked Alex Francisco Herrera (Associate Professor, Division Of Lymphoma - City of Hope National Medical Center, Duarte) at ASCO 2023, in Chicago. He explained us how N-AVD improved PFS vs BV-AVD in pts with AS HL.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay